CXCL12 and eotaxin are independent prognostic serum biomarkers in gastric cancer. [PDF]
Brodkin J +8 more
europepmc +1 more source
Chemokine Networks in Blood-Brain Barrier Regulation: Bidirectional Mechanisms, Clinical Translation, and Precision Therapeutic Prospects. [PDF]
Wu Q +5 more
europepmc +1 more source
From bud to stem: dynamics of hematopoietic stem cells that drive homing and mobilization. [PDF]
Razmkhah F, Hurwitz SN.
europepmc +1 more source
Targeting the chemokine-Treg axes in tumor immune evasion: from mechanisms to therapeutic opportunities. [PDF]
Lian C, Liu L, Zhang X.
europepmc +1 more source
CXC Chemokine-Driven Vascular Reprogramming: Modulating Tumor Vasculature to Boost Therapeutic Response. [PDF]
Chen H +7 more
europepmc +1 more source
Chemokine ligand-receptor interactions as potential therapeutic targets for atopic dermatitis: from basic to clinical research. [PDF]
Tsukamoto R +6 more
europepmc +1 more source
Chemokine-chemokine receptor axis: Emerging immunotherapeutic paradigms for solid tumor microenvironment reprogramming. [PDF]
Zhao Y +5 more
europepmc +1 more source
CXCL12-mediated T cell infiltration drives breast cancer metastasis. [PDF]
Liu X +6 more
europepmc +1 more source
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor. [PDF]
Capsoni S +9 more
europepmc +1 more source
Partial Deletion of <i>Cxcl12</i> from Hippocampal Cajal-Retzius Cells Does Not Disrupt Dentate Gyrus Development or Neurobehaviors. [PDF]
van Bruggen R +4 more
europepmc +1 more source

